Citizens JMP analyst Patrick Walravens lowered the firm’s price target on Vertex (VERX) to $50 from $61 and keeps an Outperform rating on the shares. The company reported disappointing Q2 results and it lowered its 2025 outlook, the analyst tells investors in a research note. Despite the softness, Vertex is not stepping back from the long-term outlook provided at its investor day, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERX:
- Vertex, Inc. Reports Strong Revenue Growth Amid Challenges
- Vertex, Inc. Navigates Growth Amid Challenges
- Strategic Positioning and Growth Potential: Joshua Reilly’s Buy Rating on Vertex Amid Macroeconomic Challenges
- Vertex’s Long-Term Growth Potential Outweighs Current Challenges: A Buy Recommendation
- Vertex falls -23.0%